| abstract |
The methods of treatment, prevention and / or management of macular degeneration are described. Specific modalities include the administration of an immunomodulatory compound, or a salt, solvate, hydrate, stereoisomer, clathrate or prodrug, pharmaceutically acceptable thereof, alone or in combination with a second active agent and / or surgery. Pharmaceutical compositions, simple unit dosage forms, and equipment suitable for the use of the methods of the invention are also described. |